Molecular Diagnostics Market Size - Global Industry, Share, Analysis, Trends and Forecast 2024 - 2032

CHAPTER 1. Industry Overview of Molecular Diagnostics Market

1.1. Definition and Scope

1.1.1. Definition of Molecular Diagnostics

1.1.2. Market Segmentation

1.1.3. Years Considered for the Study

1.1.4. Assumptions and Acronyms Used

1.1.4.1. Market Assumptions and Market Forecast

1.1.4.2. Acronyms Used in Global Molecular Diagnostics Market

1.2. Summary

1.2.1. Executive Summary 

1.2.2. Molecular Diagnostics Market By Product

1.2.3. Molecular Diagnostics Market By Technology

1.2.4. Molecular Diagnostics Market By Test Type

1.2.5. Molecular Diagnostics Market By Sample Type

1.2.6. Molecular Diagnostics Market By Application

1.2.7. Molecular Diagnostics Market By End-User

1.2.8. Molecular Diagnostics Market By Region

CHAPTER 2. Research Approach

2.1. Methodology 

2.1.1. Research Programs

2.1.2. Market Size Estimation

2.1.3. Market Breakdown and Data Triangulation

2.2. Data Source

2.2.1. Secondary Sources

2.2.2. Primary Sources

CHAPTER 3. Market Dynamics And Competition Analysis

3.1. Market Drivers

3.1.1. Driver 1

3.1.2. Driver 2

3.1.3. Driver 3

3.2. Restraints and Challenges

3.2.1. Restraint 1

3.2.2. Restraint 2

3.2.3. Restraint 3

3.3. Growth Opportunities

3.3.1. Opportunity 1

3.3.2. Opportunity 2 

3.3.3. Opportunity 3

3.4. Porter’s Five Forces Analysis

3.4.1. Bargaining Power of Suppliers

3.4.2. Bargaining Power of Buyers

3.4.3. Threat of Substitute

3.4.4. Threat of New Entrants

3.4.5. Degree of Competition

3.5. Market Concentration Ratio and Market Maturity Analysis of Molecular Diagnostics Market

3.5.1. Go To Market Strategy

3.5.1.1. Introduction

3.5.1.2. Growth

3.5.1.3. Maturity

3.5.1.4. Saturation

3.5.1.5. Possible Development

3.6. Technological Roadmap for Molecular Diagnostics Market

3.7. Value Chain Analysis

3.7.1. List of Key Manufacturers 

3.7.2. List of Customers

3.7.3. Level of Integration

3.8. Cost Structure Analysis

3.8.1. Price Trend of Key Raw Materials

3.8.2. Raw Material Suppliers

3.8.3. Proportion of Manufacturing Cost Structure

3.8.3.1. Raw Material

3.8.3.2. Labor Cost

3.8.3.3. Manufacturing Expense

3.9. Regulatory Compliance

3.10. Competitive Landscape, 2023

3.10.1. Player Positioning Analysis

3.10.2. Key Strategies Adopted By Leading Players

CHAPTER 4. Manufacturing Plant Analysis

4.1. Manufacturing Plant Location and Establish Date of Major Manufacturers in 2023

4.2. R&D Status of Major Manufacturers in 2023

CHAPTER 5. Molecular Diagnostics Market By Product

5.1. Introduction

5.2. Molecular Diagnostics Revenue By Product

5.2.1. Molecular Diagnostics Revenue (USD Billion) and Forecast, By Product, 2020-2032

5.2.2. Instruments

5.2.2.1. Instruments Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

5.2.3. Reagents

5.2.3.1. Reagents Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

5.2.4. Software & Services

5.2.4.1. Software & Services Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

CHAPTER 6. Molecular Diagnostics Market By Technology

6.1. Introduction

6.2. Molecular Diagnostics Revenue By Technology

6.2.1. Molecular Diagnostics Revenue (USD Billion) and Forecast, By Technology, 2020-2032

6.2.2. Polymerase Chain Reactions (PCR)

6.2.2.1. Polymerase Chain Reactions (PCR) Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

6.2.3. Isothermal Nucleic Acid Amplification Technology

6.2.3.1. Isothermal Nucleic Acid Amplification Technology Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

6.2.4. DNA Sequencing & Next- generation Sequencing

6.2.4.1. DNA Sequencing & Next- generation Sequencing Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

6.2.5. In Situ Hybridization

6.2.5.1. In Situ Hybridization Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

6.2.6. DNA Microarrays

6.2.6.1. DNA Microarrays Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

6.2.7. Other Technologies

6.2.7.1. Other Technologies Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

CHAPTER 7. Molecular Diagnostics Market By Test Type

7.1. Introduction

7.2. Molecular Diagnostics Revenue By Test Type

7.2.1. Molecular Diagnostics Revenue (USD Billion) and Forecast, By Test Type, 2020-2032

7.2.2. Lab Tests

7.2.2.1. Lab Tests Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

7.2.3. PoC Tests

7.2.3.1. PoC Tests Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

CHAPTER 8. Molecular Diagnostics Market By Sample Type

8.1. Introduction

8.2. Molecular Diagnostics Revenue By Sample Type

8.2.1. Molecular Diagnostics Revenue (USD Billion) and Forecast, By Sample Type, 2020-2032

8.2.2. Blood, Serum, and Plasma

8.2.2.1. Blood, Serum, and Plasma Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

8.2.3. Urine

8.2.3.1. Urine Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

8.2.4. Other Sample Types

8.2.4.1. Other Sample Types Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

CHAPTER 9. Molecular Diagnostics Market By Application

9.1. Introduction

9.2. Molecular Diagnostics Revenue By Application

9.2.1. Molecular Diagnostics Revenue (USD Billion) and Forecast, By Application, 2020-2032

9.2.2. Infectious Disease Diagnostics

9.2.2.1. Infectious Disease Diagnostics Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

9.2.2.2. Hepatitis

9.2.2.2.1. Hepatitis Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

9.2.2.3. HIV

9.2.2.3.1. HIV Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

9.2.2.4. CT/NG

9.2.2.4.1. CT/NG Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

9.2.2.5. HAI

9.2.2.5.1. HAI Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

9.2.2.6. HPV

9.2.2.6.1. HPV Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

9.2.2.7. Tuberculosis

9.2.2.7.1. Tuberculosis Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

9.2.2.8. Influenza

9.2.2.8.1. Influenza Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

9.2.2.9. Other Infectious Diseases

9.2.2.9.1. Other Infectious Diseases Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

9.2.3. Oncology Testing

9.2.3.1. Breast Cancer

9.2.3.1.1. Breast Cancer Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

9.2.3.2. Colorectal Cancer

9.2.3.2.1. Colorectal Cancer Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

9.2.3.3. Lung Cancer

9.2.3.3.1. Lung Cancer Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

9.2.3.4. Prostate Cancer

9.2.3.4.1. Prostate Cancer Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

9.2.3.5. Other Cancers

9.2.3.5.1. Other Cancers Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

9.2.4. Genetic Testing

9.2.4.1. Genetic Testing Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

9.2.5. Blood Screening

9.2.5.1. Blood Screening Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

9.2.6. Others

9.2.6.1. Others Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

CHAPTER 10. Molecular Diagnostics Market By End-User

10.1. Introduction

10.2. Molecular Diagnostics Revenue By End-User

10.2.1. Molecular Diagnostics Revenue (USD Billion) and Forecast, By End-User, 2020-2032

10.2.2. Diagnostic Laboratories

10.2.2.1. Diagnostic Laboratories Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

10.2.2.2. Hospitals & Clinics

10.2.2.2.1. Hospitals & Clinics Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

10.2.2.3. Other End Users

10.2.2.3.1. Other End Users Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

CHAPTER 11. North America Molecular Diagnostics Market By Country 

11.1. North America Molecular Diagnostics Market Overview

11.2. U.S.

11.2.1. U.S. Molecular Diagnostics Revenue (USD Billion) and Forecast By Product, 2020-2032

11.2.2. U.S. Molecular Diagnostics Revenue (USD Billion) and Forecast By Technology, 2020-2032

11.2.3. U.S. Molecular Diagnostics Revenue (USD Billion) and Forecast By Test Type, 2020-2032

11.2.4. U.S. Molecular Diagnostics Revenue (USD Billion) and Forecast By Sample Type, 2020-2032

11.2.5. U.S. Molecular Diagnostics Revenue (USD Billion) and Forecast By Application, 2020-2032

11.2.6. U.S. Molecular Diagnostics Revenue (USD Billion) and Forecast By End-Use, 2020-2032

11.3. Canada

11.3.1. Canada Molecular Diagnostics Revenue (USD Billion) and Forecast By Product, 2020-2032

11.3.2. Canada Molecular Diagnostics Revenue (USD Billion) and Forecast By Technology, 2020-2032

11.3.3. Canada Molecular Diagnostics Revenue (USD Billion) and Forecast By Test Type, 2020-2032

11.3.4. Canada Molecular Diagnostics Revenue (USD Billion) and Forecast By Sample Type, 2020-2032

11.3.5. Canada Molecular Diagnostics Revenue (USD Billion) and Forecast By Application, 2020-2032

11.3.6. Canada Molecular Diagnostics Revenue (USD Billion) and Forecast By End-User, 2020-2032

11.4. North America PEST Analysis

CHAPTER 12. Europe Molecular Diagnostics Market By Country

12.1. Europe Molecular Diagnostics Market Overview

12.2. U.K.

12.2.1. U.K. Molecular Diagnostics Revenue (USD Billion) and Forecast By Product, 2020-2032

12.2.2. U.K. Molecular Diagnostics Revenue (USD Billion) and Forecast  By Technology, 2020-2032

12.2.3. U.K. Molecular Diagnostics Revenue (USD Billion) and Forecast By Test Type, 2020-2032

12.2.4. U.K. Molecular Diagnostics Revenue (USD Billion) and Forecast By Sample Type, 2020-2032

12.2.5. U.K. Molecular Diagnostics Revenue (USD Billion) and Forecast By Application, 2020-2032

12.2.6. U.K. Molecular Diagnostics Revenue (USD Billion) and Forecast By End-User, 2020-2032

12.3. Germany

12.3.1. Germany Molecular Diagnostics Revenue (USD Billion) and Forecast By Product, 2020-2032

12.3.2. Germany Molecular Diagnostics Revenue (USD Billion) and Forecast  By Technology, 2020-2032

12.3.3. Germany Molecular Diagnostics Revenue (USD Billion) and Forecast By Test Type, 2020-2032

12.3.4. Germany Molecular Diagnostics Revenue (USD Billion) and Forecast By Sample Type, 2020-2032

12.3.5. Germany Molecular Diagnostics Revenue (USD Billion) and Forecast By Application, 2020-2032

12.3.6. Germany Molecular Diagnostics Revenue (USD Billion) and Forecast By End-User, 2020-2032

12.4. France

12.4.1. France Molecular Diagnostics Revenue (USD Billion) and Forecast By Product, 2020-2032

12.4.2. France Molecular Diagnostics Revenue (USD Billion) and Forecast  By Technology, 2020-2032

12.4.3. France Molecular Diagnostics Revenue (USD Billion) and Forecast By Test Type, 2020-2032

12.4.4. France Molecular Diagnostics Revenue (USD Billion) and Forecast By Sample Type, 2020-2032

12.4.5. France Molecular Diagnostics Revenue (USD Billion) and Forecast By Application, 2020-2032

12.4.6. France Molecular Diagnostics Revenue (USD Billion) and Forecast By End-User, 2020-2032

12.5. Spain

12.5.1. Spain Molecular Diagnostics Revenue (USD Billion) and Forecast By Product, 2020-2032

12.5.2. Spain Molecular Diagnostics Revenue (USD Billion) and Forecast  By Technology, 2020-2032

12.5.3. Spain Molecular Diagnostics Revenue (USD Billion) and Forecast By Test Type, 2020-2032

12.5.4. Spain Molecular Diagnostics Revenue (USD Billion) and Forecast By Sample Type, 2020-2032

12.5.5. Spain Molecular Diagnostics Revenue (USD Billion) and Forecast By Application, 2020-2032

12.5.6. Spain Molecular Diagnostics Revenue (USD Billion) and Forecast By End-User, 2020-2032

12.6. Rest of Europe

12.6.1. Rest of Europe Molecular Diagnostics Revenue (USD Billion) and Forecast By Product, 2020-2032

12.6.2. Rest of Europe Molecular Diagnostics Revenue (USD Billion) and Forecast  By Technology, 2020-2032

12.6.3. Rest of Europe Molecular Diagnostics Revenue (USD Billion) and Forecast By Test Type, 2020-2032

12.6.4. Rest of Europe Molecular Diagnostics Revenue (USD Billion) and Forecast By Sample Type, 2020-2032

12.6.5. Rest of Europe Molecular Diagnostics Revenue (USD Billion) and Forecast By Application, 2020-2032

12.6.6. Rest of Europe Molecular Diagnostics Revenue (USD Billion) and Forecast By End-User, 2020-2032

12.7. Europe PEST Analysis

CHAPTER 13. Asia Pacific Molecular Diagnostics Market By Country

13.1. Asia Pacific Molecular Diagnostics Market Overview

13.2. China

13.2.1. China Molecular Diagnostics Revenue (USD Billion) and Forecast By Product, 2020-2032

13.2.2. China Molecular Diagnostics Revenue (USD Billion) and Forecast  By Technology, 2020-2032

13.2.3. China Molecular Diagnostics Revenue (USD Billion) and Forecast By Test Type, 2020-2032

13.2.4. China Molecular Diagnostics Revenue (USD Billion) and Forecast By Sample Type, 2020-2032

13.2.5. China Molecular Diagnostics Revenue (USD Billion) and Forecast By Application, 2020-2032

13.2.6. China Molecular Diagnostics Revenue (USD Billion) and Forecast By End-User, 2020-2032

13.3. Japan

13.3.1. Japan Molecular Diagnostics Revenue (USD Billion) and Forecast By Product, 2020-2032

13.3.2. Japan Molecular Diagnostics Revenue (USD Billion) and Forecast  By Technology, 2020-2032

13.3.3. Japan Molecular Diagnostics Revenue (USD Billion) and Forecast By Test Type, 2020-2032

13.3.4. Japan Molecular Diagnostics Revenue (USD Billion) and Forecast By Sample Type, 2020-2032

13.3.5. Japan Molecular Diagnostics Revenue (USD Billion) and Forecast By Application, 2020-2032

13.3.6. Japan Molecular Diagnostics Revenue (USD Billion) and Forecast By End-User, 2020-2032

13.4. India

13.4.1. India Molecular Diagnostics Revenue (USD Billion) and Forecast By Product, 2020-2032

13.4.2. India Molecular Diagnostics Revenue (USD Billion) and Forecast  By Technology, 2020-2032

13.4.3. India Molecular Diagnostics Revenue (USD Billion) and Forecast By Test Type, 2020-2032

13.4.4. India Molecular Diagnostics Revenue (USD Billion) and Forecast By Sample Type, 2020-2032

13.4.5. India Molecular Diagnostics Revenue (USD Billion) and Forecast By Application, 2020-2032

13.4.6. India Molecular Diagnostics Revenue (USD Billion) and Forecast By End-User, 2020-2032

13.5. Australia

13.5.1. Australia Molecular Diagnostics Revenue (USD Billion) and Forecast By Product, 2020-2032

13.5.2. Australia Molecular Diagnostics Revenue (USD Billion) and Forecast  By Technology, 2020-2032

13.5.3. Australia Molecular Diagnostics Revenue (USD Billion) and Forecast By Test Type, 2020-2032

13.5.4. Australia Molecular Diagnostics Revenue (USD Billion) and Forecast By Sample Type, 2020-2032

13.5.5. Australia Molecular Diagnostics Revenue (USD Billion) and Forecast By Application, 2020-2032

13.5.6. Australia Molecular Diagnostics Revenue (USD Billion) and Forecast By End-User, 2020-2032

13.6. South Korea

13.6.1. South Korea Molecular Diagnostics Revenue (USD Billion) and Forecast By Product, 2020-2032

13.6.2. South Korea Molecular Diagnostics Revenue (USD Billion) and Forecast  By Technology, 2020-2032

13.6.3. South Korea Molecular Diagnostics Revenue (USD Billion) and Forecast By Test Type, 2020-2032

13.6.4. South Korea Molecular Diagnostics Revenue (USD Billion) and Forecast By Sample Type, 2020-2032

13.6.5. South Korea Molecular Diagnostics Revenue (USD Billion) and Forecast By Application, 2020-2032

13.6.6. South Korea Molecular Diagnostics Revenue (USD Billion) and Forecast By End-User, 2020-2032

13.7. Rest of Asia-Pacific

13.7.1. Rest of Asia-Pacific Molecular Diagnostics Revenue (USD Billion) and Forecast By Product, 2020-2032

13.7.2. Rest of Asia-Pacific Molecular Diagnostics Revenue (USD Billion) and Forecast  By Technology, 2020-2032

13.7.3. Rest of Asia-Pacific Molecular Diagnostics Revenue (USD Billion) and Forecast By Test Type, 2020-2032

13.7.4. Rest of Asia-Pacific Molecular Diagnostics Revenue (USD Billion) and Forecast By Sample Type, 2020-2032

13.7.5. Rest of Asia-Pacific Molecular Diagnostics Revenue (USD Billion) and Forecast By Application, 2020-2032

13.7.6. Rest of Asia-Pacific Molecular Diagnostics Revenue (USD Billion) and Forecast By End-User, 2020-2032

13.8. Asia Pacific PEST Analysis

CHAPTER 14. Latin America Molecular Diagnostics Market By Country

14.1. Latin America Molecular Diagnostics Market Overview

14.2. Brazil

14.2.1. Brazil Molecular Diagnostics Revenue (USD Billion) and Forecast By Product, 2020-2032

14.2.2. Brazil Molecular Diagnostics Revenue (USD Billion) and Forecast  By Technology, 2020-2032

14.2.3. Brazil Molecular Diagnostics Revenue (USD Billion) and Forecast By Test Type, 2020-2032

14.2.4. Brazil Molecular Diagnostics Revenue (USD Billion) and Forecast By Sample Type, 2020-2032

14.2.5. Brazil Molecular Diagnostics Revenue (USD Billion) and Forecast By Application, 2020-2032

14.2.6. Brazil Molecular Diagnostics Revenue (USD Billion) and Forecast By End-User, 2020-2032

14.3. Mexico

14.3.1. Mexico Molecular Diagnostics Revenue (USD Billion) and Forecast By Product, 2020-2032

14.3.2. Mexico Molecular Diagnostics Revenue (USD Billion) and Forecast  By Technology, 2020-2032

14.3.3. Mexico Molecular Diagnostics Revenue (USD Billion) and Forecast By Test Type, 2020-2032

14.3.4. Mexico Molecular Diagnostics Revenue (USD Billion) and Forecast By Sample Type, 2020-2032

14.3.5. Mexico Molecular Diagnostics Revenue (USD Billion) and Forecast By Application, 2020-2032

14.3.6. Mexico Molecular Diagnostics Revenue (USD Billion) and Forecast By End-User, 2020-2032

14.4. Rest of Latin America

14.4.1. Rest of Latin America Molecular Diagnostics Revenue (USD Billion) and Forecast By Product, 2020-2032

14.4.2. Rest of Latin America Molecular Diagnostics Revenue (USD Billion) and Forecast  By Technology, 2020-2032

14.4.3. Rest of Latin America Molecular Diagnostics Revenue (USD Billion) and Forecast By Test Type, 2020-2032

14.4.4. Rest of Latin America Molecular Diagnostics Revenue (USD Billion) and Forecast By Sample Type, 2020-2032

14.4.5. Rest of Latin America Molecular Diagnostics Revenue (USD Billion) and Forecast By Application, 2020-2032

14.4.6. Rest of Latin America Molecular Diagnostics Revenue (USD Billion) and Forecast By End-User, 2020-2032

14.5. Latin America PEST Analysis

CHAPTER 15. Middle East & Africa Molecular Diagnostics Market By Country 

15.1. Middle East & Africa Molecular Diagnostics Market Overview

15.2. GCC

15.2.1. GCC Molecular Diagnostics Revenue (USD Billion) and Forecast By Product, 2020-2032

15.2.2. GCC Molecular Diagnostics Revenue (USD Billion) and Forecast  By Technology, 2020-2032

15.2.3. GCC Molecular Diagnostics Revenue (USD Billion) and Forecast By Test Type, 2020-2032

15.2.4. GCC Molecular Diagnostics Revenue (USD Billion) and Forecast By Sample Type, 2020-2032

15.2.5. Molecular Diagnostics Revenue (USD Billion) and Forecast By Application, 2020-2032

15.2.6. Molecular Diagnostics Revenue (USD Billion) and Forecast By End-User, 2020-2032

15.3. South Africa

15.3.1. South Africa Molecular Diagnostics Revenue (USD Billion) and Forecast By Product, 2020-2032

15.3.2. South Africa Molecular Diagnostics Revenue (USD Billion) and Forecast  By Technology, 2020-2032

15.3.3. South Africa Molecular Diagnostics Revenue (USD Billion) and Forecast By Test Type, 2020-2032

15.3.4. South Africa Molecular Diagnostics Revenue (USD Billion) and Forecast By Sample Type, 2020-2032

15.3.5. South Africa Molecular Diagnostics Revenue (USD Billion) and Forecast By Application, 2020-2032

15.3.6. South Africa Molecular Diagnostics Revenue (USD Billion) and Forecast By End-User, 2020-2032

15.4. Rest of Middle East & Africa

15.4.1. Rest of Middle East & Africa Molecular Diagnostics Revenue (USD Billion) and Forecast By Product, 2020-2032

15.4.2. Rest of Middle East & Africa Molecular Diagnostics Revenue (USD Billion) and Forecast By Technology, 2020-2032

15.4.3. Rest of Middle East & Africa Molecular Diagnostics Revenue (USD Billion) and Forecast By Test Type, 2020-2032

15.4.4. Rest of Middle East & Africa Molecular Diagnostics Revenue (USD Billion) and Forecast By Sample Type, 2020-2032

15.4.5. Rest of Middle East & Africa Molecular Diagnostics Revenue (USD Billion) and Forecast By Application, 2020-2032

15.4.6. Rest of Middle East & Africa Molecular Diagnostics Revenue (USD Billion) and Forecast By End-User, 2020-2032

15.5. Middle East & Africa PEST Analysis

CHAPTER 16. Player Analysis Of Molecular Diagnostics Market

16.1. Molecular Diagnostics Market Company Share Analysis

16.2. Competition Matrix

16.2.1. Competitive Benchmarking of key players by price, presence, market share, and R&D investment

16.2.2. New Product Launches and Product Enhancement

16.2.3. Mergers And Acquisition In Global Molecular Diagnostics Market

16.2.4. Partnership, Joint Ventures and Strategic Alliances/ Sales Agreements

CHAPTER 17. Company Profile

17.1. Siemens Healthineers

17.1.1. Company Snapshot

17.1.2. Business Overview

17.1.3. Financial Overview

17.1.3.1. Revenue (USD Billion), 2023

17.1.3.2. Siemens Healthineers Ingredients Ltd. 2023 Molecular Diagnostics Business Regional Distribution

17.1.4. Product /Service and Specification

17.1.5. Recent Developments & Business Strategy

17.2. Johnson and Johnson

17.3. Abbott Molecular

17.4. Cepheid

17.5. Analytik Jena

17.6. Alere Inc.

17.7. BIOMÉRIEUX India Pvt. Ltd.

17.8. GenMark Diagnostics, Inc.

17.9. Roche Diagnostics India Pvt Ltd.

17.10. Agilent Technologies

17.11. Danaher Corporation

17.12. QIAGEN Sciences Inc.